Seitzer, K.E.; Seifert, R.; Kessel, K.; Roll, W.; Schlack, K.; Boegemann, M.; Rahbar, K.
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives. Cancers 2021, 13, 3715.
https://doi.org/10.3390/cancers13153715
AMA Style
Seitzer KE, Seifert R, Kessel K, Roll W, Schlack K, Boegemann M, Rahbar K.
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives. Cancers. 2021; 13(15):3715.
https://doi.org/10.3390/cancers13153715
Chicago/Turabian Style
Seitzer, Konstantin Egon, Robert Seifert, Katharina Kessel, Wolfgang Roll, Katrin Schlack, Martin Boegemann, and Kambiz Rahbar.
2021. "Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives" Cancers 13, no. 15: 3715.
https://doi.org/10.3390/cancers13153715
APA Style
Seitzer, K. E., Seifert, R., Kessel, K., Roll, W., Schlack, K., Boegemann, M., & Rahbar, K.
(2021). Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives. Cancers, 13(15), 3715.
https://doi.org/10.3390/cancers13153715